CAS No.:50-52-2

TOXICITY DATA with REFERENCE：

1.		sln-dmg-orl 100 mg/L		IJEBA6    Indian Journal of Experimental Biology. 11 (1973),403.
2.		orl-cld TDLo:28 mg/kg/2W-I		AJPSAO    American Journal of Psychiatry. 143 (1985),1176.
3.		orl-cld TDLo:28 mg/kg/2W-I:BAH		AJPSAO    American Journal of Psychiatry. 143 (1985),1176.
4.		orl-wmn TDLo:14,500 mg/kg/15Y-I:EYE		CMAJAX    Canadian Medical Association Journal. 132 (1985),737.
5.		orl-hmn LDLo:43 mg/kg		ARGPAQ    Archives of General Psychiatry. 34 (1977),955.
6.		orl-chd TDLo:25 mg/kg:CNS,CVS		AJDCAI    American Journal of Diseases of Children. 130 (1976),507.
7.		orl-hmn TDLo:24 mg/kg:ANS AACRAT 52,938,73
8.		orl-rat LD50:995 mg/kg		TXAPA9    Toxicology and Applied Pharmacology. 18 (1971),185.
9.		ipr-rat LD50:150 mg/kg		PCJOAU    Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. 10 (1976),1001.
10.		scu-rat LD50:640 mg/kg		MDCHAG    Medicinal Chemistry: A Series of Monographs. 4 (1967),199.

Consensus Reports：

EPA Genetic Toxicology Program.

SAFETY PROFILE：

Human poison by ingestion. Experimental poison by ingestion, subcutaneous, and intraperitoneal routes. Human systemic effects by ingestion: heart rate change, muscle contraction or spasticity, parasympatholytic, toxic psychosis, visual field and retinal changes. Human reproductive effects. Experimental reproductive effects. Mutation data reported. An antipsychotic and sedative. When heated to decomposition it emits very toxic fumes of NO_x and SO_x.

Standards and Recommendations：

 

Analytical Methods：